Search

The emerging pandemic situation has created unease and dismay at every level, from governing bodies to population and from pharmaceutical manufacturers to front-line servers. Everyone is scarified by the death-dealing and ruinous effects of COVID-19. The encouraging and positive news about vaccine development and successful trials of vaccine proved to be remedial, but another dilemma arises in the form of mutation of the deadly virus. Question marks are arising about the lethality of mutated strain, lack of management and protective measures by the governing bodies, and ambiguities are aroused about the effectiveness of vaccines against them. After an all-inclusive and particularized study and genomic examination of the virus, the researchers have put forward the details that Coronavirus Mutation is Worrying but Not Terrifying. The upshot is that it is required to screen, but at present, their mark suggests that the new strain in the UK is more transmissible but neither severe nor resistant.

Classical prodrug design is a sweeping approach to throw away futile side effects related to drug therapy. The main purpose of prodrug designing is to ameliorate physicochemical, pharmaceutical, and pharmacokinetic characteristics of particular compounds to resolve issues like formulation, delivery to the target site, and toxicity limitations. To fabricate the pharmacological action in CNS, drugs must cross the blood-brain barrier (BBB). Therefore, prodrug strategies are designed which include lipidization and the use of carriers and transporters. In this article, we have reviewed different anticancer, neuroprotective, and antiviral prodrugs. Flurbiprofen prodrugs, glycosylated prodrugs, resveratrol prodrugs, levodopa, etc., are mapped out for neurodegenerative disorders in CNS. Due to the poor oral pharmacokinetic properties of antiviral agents, drug design methods are performed by combining the parent drug molecule with a number of active components such as dipeptide esters, amino acids, nucleosides, and macromolecular-based prodrugs.

A multiple dose regimen is a concept that is used for certain diseases as arthritis, heart diseases etc. It is used to increase the therapeutic activity and clinical efficacy of the drugs. Drugs are usually used in single doses to produce acute effect but in cases where chronic affect is required multiple dosage regimen is required. Designing the dosage regimen and maintaining the drug concentration in blood plasma after administration are the primary goals to achieve safety and efficacy. That is to maintain drug concentration in therapeutic window. Moreover, the IV infusion and continuous IV diffusion is reviewed.

Gout is one of the utmost encountered inflammatory arthritis in clinical practice. The purpose of this article is to review the pathophysiology, management and epidemiology of acute and chronic gout. The occurrence of gout throughout the globe has also been documented. Therapies for pain management during gout have also been discussed. Treatment medications of gout can be mainly classified as uricosurics and uric acid synthesis inhibitors, these are discussed in detail in reference to their pharmacokinetics.

Parenteral site of administration of drug provides several advantages. In subcutaneous administration of the drug mainly move to the capillaries from the site of action. However, in case of the intraperitoneal administration the peritoneal cavity of is the target. Different experimental animal requires certain criteria to deliver the dose of the drugs. All the parameter is vital to perform experiment on animals. We have search different search engine PubMed, Tadfoline, Goggle Scholar etc. Methods along with the precautionary measure and safety issue are discussed. Also, various steps area defined for administration of drugs in experimental work. The main purpose of this review is to gather the work realter to intra peritoneal and sub cutaneous administration of the drugs.

Triamcinolone acetonide is an antiinflammatory drug that has been used for more than 50 years for the treatment of various inflammatory disorders including the arthritis & gout etc. Moreover, in recent years its use has been rapidly increased for the treatment of retinal vasculature disease and Uveitis, periocular and intraocular treatment. This review summarizes the whole manufacturing process of this formulation along with the complete in-process QC & Finished dosage form test parameters that ensures the efficacy and safety of this drug. Furthermore, the industrial requirements in the production and QC department to manufacture this product are emphasized to optimize the production as well as the quality of the Product.

Flu is caused by influenza A and B virus leading an acute respiratory illness. This review summarizes advance diagnostic techniques for detecting and confirming influenza virus and treatments involve. RADTS are beneficial tools but with the limited sensitivity. Pandemic confirmation H1N1 influenza A infection done by real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) or viral culture. Several approaches are as of now accessible for determination of flu contaminations like serological tests are generally used to identify flu infection in immunizer reactions incorporate hemagglutination restraint test that depends on capacity of HA-explicit antibodies. Rapid molecular assays that produces results in approximately in 15-30minutes by detecting nucleic acids of influenza in upper respiratory tract. For treating influenza antiviral medications are given to patients based on clinical and epidemiological factors. Neuraminidase inhibitor (NI) is the drug of choice. A good way to prevent the disease is to give individuals annual vaccine and another way is to start an early diagnosis and give medications in short time to patients to prevent further spread of disease and reduce complications otherwise.

Neuromodulation therapies generally deal with the provision of pain management, treatment of movement disorders, seizure control by the utilization of brain-controlled devices to individuals with compromised movement. Recent advancement in optogenetics has led to the development of techniques to explore the neural circuitry & biomarkers to track the progression of disease in neurodegenerative disorders. Further advancements contributing to neuromodulation therapies include engineering of nanotechnology, advances in genetics, exome sequencing and novel imaging techniques to detect connectivity deficits in motor and sensory networks that have been associated with neurological disorders. The following six neuromodulation therapies will be discussed in detail herein reference to neurologist awareness, candidate selection, and barriers to treatment. This article highlights the appropriate selection of neuromodulation therapy in the management of chronic pain and neurodegenerative orders that can lead to short-term and longterm clinical benefits.

In modern day, Data on different diseases and drug substances with their properties like modification, side effects, and dose requires documentation data and building library exploring, such library with vast information in every aspect needs computational methods used in CADD. Recognition of specific targets for the drug tested and defining pharmacological activity of a drug candidate based on the structure of both drug and its target, finding outside effects of drugs at the molecular level and calculation of toxicity caused by metabolism of drug applications of Computer aided drug design in the drug discovery process. We can get additional tools and websites which serve As a tool for the source of data and computational drug design are available on the web interface and being used extensively by researchers and scientists to save time and budget for speeding up the process of experiments for Novel Drug compound.

New drugs are mostly obtained from Natural sources. The traditional and ethic medicines have provided evidence on the therapeutic properties and resulted in some distinguished drug discovery of natural products. The microorganisms and the endogenous active materials from human or animal have also become a significant approach to the discovery of a drug. Bioinformatics and artificial intelligence have facilitated the study and development of products. For discovery of natural products different software have been used. Different computational software needed in the future for the predicting features in new drug development, for instance pharmacokinetic and pharmacodynamics, in drug development lead positive impact. This review focus on natural product drug discovery and uses innovative strategies and techniques as a part of discovery of drugs from natural products.

Viral hepatitis B and Viral hepatitis C are one of the leading causes of disease and death in the present-day world. These viruses greatly affect the liver by causing inflammation, cirrhosis, fibrosis, hepatocellular carcinoma (HCC) and even causes the death of affected individuals. It requires highly cautious treatment to resolve complications associated with it, including abnormal levels of serological molecules of specific antigens, antibodies and liver enzymes. The treatment involves the use of antiviral agents that fight against viral antigens, reverses the progression of the disease and also prevents morbidity. Further reading takes towards the development of safe and effective antiviral agents and other regimens for lessening complications and ensuring patient compliance. Moreover, vaccines are also available that fight against the virus and act to prevent the emergence of viral hepatitis. Future developments are today in clinical trials to produce safer and efficacious agents to combat and prevent this disease.

In several pharmacologic, pharmacology, and alternative medicine studies, oral administration of medication or test substances to experimental animals is needed. It is clinically sound and recommended to administer test substances to experimental animals along the same route that they are taken or expected to be taken by humans as general bioavailability; the pharmacology and pharmacology parameters obtained for the drug will depend significantly on the route chosen to administer it. The lack of ready access to high-quality oral tubing built for different species, as well as a widespread lack of technical expertise to properly use out-of-the-box techniques in this part of the world, has made this route controversial among medicine scientists. The typical problems and difficulties associated with the oral administration of test product solutions were avoided by mistreating either the syringe alone or incorporating it into the animals feeds or drinkables. This jury-rigged oral tubing was also used to ensure that the expected doses were correctly administered in each case.

Pharmacokinetic modeling helps to estimate the ADME parameters of all the natural and synthetic drug substances in humans and animals. There are two types of approaches for predicting the kinetic processes inside the body i.e., model approach and model independent approach. Model approach is further divided into compartmental and physiological models and model independent approach consists of non-compartmental models. Compartmental modeling is the most widely used approach. It visually shows the rate processes of drug deposition and also predict the drug concentration time graph. Compartmental model consists of catenary and mammillary models. Mammillary models can either be one compartment, multi compartment or two compartments. The physiologically based pharmacokinetic models consists of compartments that correlates with various body tissues, connected by blood circulatory system. Another name for non- compartmental analysis is model-independent approach that means it does not require any compartment model.

Mathematical model a numerical classification of the biological framework and utilized to state quantitative connections. A pharmacokinetic compartment is a numerical idea that portrays a space in the body that medication seems to possess These models just mediate the test information and permit an experimental equation for the assessment of medication focus with time. A non- compartmental model is a pharmacokinetic model that does not involve the consequence of a definite compartment model is called a Non-compartment model. This approach is based on the consequence that the drugs or substances created in a metabolic process follow direct kinetics, which is the basis that this approach can be functional to any compartment model. The non- compartmental analysis gives an elective strategy to portraying drug pharmacokinetics without appointing a specific compartmental model to the medication.

The rapid change in the failure of antimicrobial therapy due to an increase in the number of infections caused by antimicrobial resistance and the commencement of comprehensive resistant strains robustly claim detection of appliances causing the improvement of drug resistance. In this article, we review the double tactics to decrease antimicrobial resistance infections in hospitals by the improvement of hospital infection prevention and control (IPC) and Antimicrobial Stewardship (AMS) programs and their gradually significant part in decreasing the feast of antibiotic resistance using an ethical framework that enables clinicians and to appraise policies for rational use of an antibiotic in six practical steps. Though the procedure of bacteriophages and antibodies has been partially applied, further encouraging plans, such as probiotics and antimicrobial peptides, are under improvement. Novel approaches such as genetically modified phages and CRISPRCas9 also converse, and plasmid curing and anti-plasmid methods might reduce ARG existence and alert bacteria about antibiotics.

With time viral infections are increasing day by day due to various reasons like new viruses, the resistance of viruses to antiviral therapy, and mutation of one form of the virus to another form; these types of problems create many challenges in the field of research. Furthermore, a lot of challenges are encountered in the treatment of antiviral therapy, like interaction with other medication and use of increased frequency and a high dose of antiviral due to infection in CNS or synovial fluid where drug permeation is less. Consequently, toxicity and other side effect chances will be more. Nano-technological approaches are used to overcome these challenges. The beneficial properties come from such engineering, including stimuli sensitivity, targetability, and longevity; these are all combined to give multifunctional nano-carriers that concurrently execute different beneficial tasks